R
Roquefort Therapeutics PLC
LSE:ROQ
Roquefort Therapeutics PLC
LSE:ROQ
Price:
9.25
GBX
873.68%
Market Cap:
£15.1m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
R
|
Roquefort Therapeutics PLC
LSE:ROQ
|
UK |
|
Ascentage Pharma Group International
HKEX:6855
|
CN |
|
S
|
Sheela Foam Ltd
BSE:540203
|
IN |
|
Kirin Holdings Co Ltd
TSE:2503
|
JP |
|
A
|
Asian Capital Resources (Holdings) Ltd
HKEX:8025
|
HK |
Balance Sheet
Balance Sheet Decomposition
Roquefort Therapeutics PLC
Roquefort Therapeutics PLC
Balance Sheet Decomposition is not available for
Roquefort Therapeutics PLC
Roquefort Therapeutics PLC
Balance Sheet
Roquefort Therapeutics PLC
Roquefort Therapeutics PLC
Currency: GBP
| Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|
| Assets | |||||
| Cash & Cash Equivalents |
1
|
0
|
1
|
0
|
|
| Cash |
0
|
0
|
1
|
0
|
|
| Cash Equivalents |
1
|
0
|
0
|
0
|
|
| Total Receivables |
2
|
0
|
0
|
0
|
|
| Accounts Receivables |
2
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
|
| Total Current Assets |
3
|
2
|
1
|
0
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
|
| Intangible Assets |
1
|
5
|
5
|
5
|
|
| Goodwill |
0
|
0
|
0
|
0
|
|
| Other Assets |
0
|
0
|
0
|
0
|
|
| Total Assets |
5
N/A
|
8
+70%
|
6
-22%
|
6
-6%
|
|
| Liabilities | |||||
| Accounts Payable |
0
|
0
|
0
|
0
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
0
|
0
|
1
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
1
+17%
|
1
+5%
|
1
+46%
|
|
| Equity | |||||
| Common Stock |
1
|
1
|
1
|
1
|
|
| Retained Earnings |
1
|
2
|
0
|
1
|
|
| Additional Paid In Capital |
4
|
4
|
4
|
5
|
|
| Other Equity |
0
|
0
|
0
|
0
|
|
| Total Equity |
4
N/A
|
7
+77%
|
5
-24%
|
5
-11%
|
|
| Total Liabilities & Equity |
5
N/A
|
8
+70%
|
6
-22%
|
6
-6%
|
|
| Shares Outstanding | |||||
| Common Shares Outstanding |
72
|
129
|
129
|
136
|
|
Switch to:
Switch to:
See Also
Discover More
